Recombinant humanized anti-HER2 antibody (HERCEPTIN) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts - Baselga, J; Norton, L; Albanell, J (Cancer Res, 1998)
et al.